As a sponsor for the third annual OneMedForum New York to be held July 11-12, BDO Life Sciences will host a special workshop to discuss compensation practices at life sciences companies.
According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer.
OncoSec Medical is a biopharmaceutical company developing advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers and metastatic disease.
Ceplene is administered for maintenance of first remission in patients with AML, the most common type of Leukemia in adults.
S.E.A. Medical Systems, Inc. is developing solutions for making intravenous (IV) drug delivery safer for patients.
GlySure has developed an intravascular sensor capable of continuously monitoring a patient’s glucose for the length of their stay in the ICU.
DATATRAK International, Inc. announced translation of DATATRAK ONE to Simplified Chinese
Results of a published prospective three-year clinical study have demonstrated that the Reducer is safe and effective at providing relief of angina symptoms in refractory angina patients.
IntelGenx is at the forefront of the industry with CPI-300 being the only single dose 450 mg formulation of Bupropion HCl approved by the FDA.
VisionCare’s lead product, Implantable Miniature Telescope by Dr. Isaac Liphitz, enlarges images in front of the eye approximately 2.5 times their normal size.
Copyright © 2025 | WordPress Theme by MH Themes